Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 18.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,219 shares of the company’s stock after purchasing an additional 1,102 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Prestige Consumer Healthcare were worth $564,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets raised its stake in Prestige Consumer Healthcare by 276.2% during the third quarter. BNP Paribas Financial Markets now owns 17,379 shares of the company’s stock worth $1,253,000 after purchasing an additional 12,759 shares during the period. HighTower Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 4.9% during the 3rd quarter. HighTower Advisors LLC now owns 16,708 shares of the company’s stock valued at $1,215,000 after buying an additional 774 shares during the period. Stifel Financial Corp lifted its holdings in Prestige Consumer Healthcare by 13.7% in the third quarter. Stifel Financial Corp now owns 19,299 shares of the company’s stock valued at $1,391,000 after acquiring an additional 2,322 shares during the last quarter. Wellington Management Group LLP purchased a new position in Prestige Consumer Healthcare in the third quarter worth approximately $6,342,000. Finally, Jane Street Group LLC increased its stake in Prestige Consumer Healthcare by 28.3% during the third quarter. Jane Street Group LLC now owns 65,373 shares of the company’s stock worth $4,713,000 after acquiring an additional 14,434 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on PBH shares. Canaccord Genuity Group increased their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Royal Bank of Canada increased their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research note on Friday, March 21st. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, DA Davidson boosted their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of “Hold” and an average target price of $93.33.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Trading Down 2.1 %

NYSE:PBH opened at $79.72 on Wednesday. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The firm has a market cap of $3.95 billion, a PE ratio of 18.67, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock has a fifty day moving average price of $84.10 and a 200 day moving average price of $79.58.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.